Drug intelligence / Profile preview

LR19094

Development stage: Unknown
Lead developer: LG Chem
Administration: Local Dermal Injection

Overview

LR19094 is a hyaluronic acid (HA) dermal filler developed by LG Chem (CHEMS). Classified as a medical device, it is designed for aesthetic applications, specifically for volumizing and dermal augmentation through local dermal injection. The product is currently in Phase 3 clinical development, aiming to provide structural support and aesthetic improvement of the skin by replenishing volume in targeted areas.

Beyond the preview

Go deeper on LR19094.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LR19094.

Explore the full profile